{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:22:37Z","timestamp":1765380157311,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA102282"],"award-info":[{"award-number":["R01CA102282"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbmt.2016.10.022","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T21:45:59Z","timestamp":1478036759000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Chien-Chun Steven","family":"Pai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lam T.","family":"Khuat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-0480","authenticated-orcid":false,"given":"Mingyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.10.022_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0015","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.bbmt.2014.12.033","article-title":"Reprint of: B cells in chronic graft-versus-host disease","volume":"21(2 Suppl)","author":"Sarantopoulos","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0020","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-02-486373","article-title":"Neddylation plays an important role in the regulation of murine and human dendritic cell function","volume":"122","author":"Mathewson","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0025","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/leu.2014.195","article-title":"Next generation treatment of acute graft-versus-host disease","volume":"28","author":"Magenau","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0030","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/embor.2008.183","article-title":"Function and regulation of protein neddylation. \u201cProtein modifications: beyond the usual suspects\u201d review series","volume":"9","author":"Rabut","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-13-0987","article-title":"The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-kappaB activation and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"20","author":"Godbersen","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0040","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-12-0388","article-title":"The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth","volume":"72","author":"Luo","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0045","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI76094","article-title":"Targeting cancer with kinase inhibitors","volume":"125","author":"Gross","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0050","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2014-02-554279","article-title":"Treatment of chronic graft-versus-host disease with bortezomib","volume":"124","author":"Pai","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0055","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0060","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2010-03-272567","article-title":"MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma","volume":"116","author":"Milhollen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0065","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/bjh.13323","article-title":"Pevonedistat (MLN4924), a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study","volume":"169","author":"Swords","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0070","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2015.106","article-title":"Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in FLT3-ITD acute myeloid leukemia","volume":"29","author":"Khalife","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0075","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2004-01-0328","article-title":"Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease","volume":"104","author":"Anderson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0080","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1084\/jem.20071733","article-title":"Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state","volume":"204","author":"Ginhoux","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0085","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1182\/blood-2004-11-4526","article-title":"Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity","volume":"106","author":"Sun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0090","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1172\/JCI75935","article-title":"CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease","volume":"124","author":"Alexander","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0095","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bbmt.2014.04.028","article-title":"Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects","volume":"20","author":"Johnston","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4049\/jimmunol.1200677","article-title":"Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease","volume":"189","author":"Young","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0105","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1073\/pnas.0401563101","article-title":"Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib","volume":"101","author":"Sun","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ccr.2012.02.009","article-title":"Treatment-emergent mutations in NAEbeta confer resistance to the NEDD8-activating enzyme inhibitor MLN4924","volume":"21","author":"Milhollen","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0115","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/1078-0432.CCR-09-0343","article-title":"Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer","volume":"15","author":"Soucy","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0120","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0125","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood-2005-09-3623","article-title":"Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0130","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2008-03-143461","article-title":"Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation","volume":"112","author":"Sun","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20101559","article-title":"The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells","volume":"208","author":"Takashima","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0140","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.bbmt.2014.07.022","article-title":"Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels","volume":"20","author":"Pai","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.022_bib0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/1078-0432.CCR-15-1237","article-title":"Phase I study of the novel investigational NEDD8-activating enzyme inhibitor pevonedistat (MLN4924) in patients with relapsed\/refractory multiple myeloma or lymphoma","volume":"22","author":"Shah","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116304578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116304578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:35Z","timestamp":1761058655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116304578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1083879116304578"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.022","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}